Ballentine Partners’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$301K Buy
4,094
+72
+2% +$5.29K ﹤0.01% 689
2025
Q1
$459K Buy
4,022
+48
+1% +$5.48K 0.01% 472
2024
Q4
$200K Buy
+3,974
New +$200K ﹤0.01% 787